Aditxt, Inc.
Pharmaceutical Preparations · RICHMOND
Moderate confidence (50%)
Updated Oct 15, 2026, 12:02 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Aditxt, Inc. was delisted from its exchange (Oct 7, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Aditxt, Inc. was delisted from its exchange
Oct 7, 2026
Delisting effective
- SEC EDGAR — “X0203 0001354457 Nasdaq Stock Market LLC 0001726711 Aditxt, Inc. 001-39336 11161 Anderson Street Suite 105-10014 Loma Linda CA CALIFORNIA 92354 951-316-9002 Common Stock 17 CFR 240.12d2-2(b) Aravind Menon Hearings Advisor 2026-10-07”
Aditxt, Inc. received a delisting notice from its exchange
Sep 17, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on June 23, 2026, the Nasdaq Hearings Panel notified Aditxt, Inc. (the Company ) that it had denied the Company s request to continue the listing of its common stock on The Nasdaq Stock Market LLC ( Nasdaq ) and that trading in the Company s common stock would be suspended effective at the open of trading on June 25, 2026. Trading in the Company s common stock on Nasdaq has been suspended since that time. On September 17, 2026, Nasdaq publicly announced that…”
Aditxt, Inc. received a delisting notice from its exchange
Jun 23, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 6, 2026. as previously reported in a Current Report on Form 8-K filed by Aditxt, Inc. (the Company ) on May 8, 2026, the Company received formal notice (the May 6 th Letter ) from the Staff of the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) that Nasdaq Staff had determined to delist the Company s securities from Nasdaq. In the May 6 th Letter, the Staff stated that the bid price of the Company s listed securities had closed at less…”
Aditxt, Inc. received a delisting notice from its exchange
May 27, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 27, 2026, Aditxt, Inc. (the Company ) received a letter (the Letter ) from the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the stockholders equity of $(35,174,386) reported in the Company s Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the Form 10-Q ), the Company no longer satisfies the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasdaq Capit…”
Aditxt, Inc. received a delisting notice from its exchange
May 6, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 6, 2026, Aditxt, Inc. (the Company ) received a Staff Determination letter (the Staff Determination ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that Nasdaq Staff had determined to delist the Company s securities from The Nasdaq Capital Market. The Staff Determination stated that the bid price of the Company s listed securities had closed at less than $1.00 per share over the previous 30 consecutive business days,…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker ADTX on OTC.
- SEC CIK
- 0001726711
- Website
- —
- —
- Headquarters
- RICHMOND
- Also known as
- ADiTx Therapeutics, Inc.
- Legal entities
- Aditxt, Inc.
Sources
Every material source used to build this profile.
SEC EDGAR (TIER 1 · UNVERIFIED)
X0203 0001354457 Nasdaq Stock Market LLC 0001726711 Aditxt, Inc. 001-39336 11161 Anderson Street Suite 105-10014 Loma Linda CA CALIFORNIA 92354 951-316-9002 Common Stock 17 CFR 240.12d2-2(b) Aravind Menon Hearings Advisor 2026-10-07
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on June 23, 2026, the Nasdaq Hearings Panel notified Aditxt, Inc. (the Company ) that it had denied the Company s request to continue the listing of its common stock on The Nasdaq Stock Market LLC ( Nasdaq ) and that trading in the Company s common stock would be suspended effective at the open of trading on June 25, 2026. Trading in the Company s common stock on Nasdaq has been suspended since that time. On September 17, 2026, Nasdaq publicly announced that…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 27, 2026, Aditxt, Inc. (the Company ) received a letter (the Letter ) from the Listing Qualifications Staff (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that, based on the stockholders equity of $(35,174,386) reported in the Company s Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the Form 10-Q ), the Company no longer satisfies the minimum stockholders equity requirement of $2,500,000 for continued listing on The Nasdaq Capit…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 6, 2026, Aditxt, Inc. (the Company ) received a Staff Determination letter (the Staff Determination ) from the Listing Qualifications Department of The Nasdaq Stock Market LLC ( Nasdaq ) notifying the Company that Nasdaq Staff had determined to delist the Company s securities from The Nasdaq Capital Market. The Staff Determination stated that the bid price of the Company s listed securities had closed at less than $1.00 per share over the previous 30 consecutive business days,…
View source recordSEC Company Submissions (TIER 1 · UNVERIFIED)
Aditxt, Inc. — Pharmaceutical Preparations (SIC 2834) — RICHMOND, VA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 6, 2026. as previously reported in a Current Report on Form 8-K filed by Aditxt, Inc. (the Company ) on May 8, 2026, the Company received formal notice (the May 6 th Letter ) from the Staff of the Listing Qualifications Department (the Staff ) of The Nasdaq Stock Market LLC ( Nasdaq ) that Nasdaq Staff had determined to delist the Company s securities from Nasdaq. In the May 6 th Letter, the Staff stated that the bid price of the Company s listed securities had closed at less…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:34 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:05 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 11, 2026, 12:02 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:16 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.